{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:29:32Z","timestamp":1790562572634,"version":"4.1.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11154-025-09972-7","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T23:48:59Z","timestamp":1751845739000},"page":"989-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Endocrine and metabolic consequences of childhood-onset craniopharyngioma during the transition age: A literature review by the TALENT study group"],"prefix":"10.1007","volume":"26","author":[{"given":"Dario","family":"De Alcubierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Feola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Puliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Ferrigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisa","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"d\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Pirchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pandozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Gianfrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"11","key":"9972_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrendo.2010.168","volume":"6","author":"HL Muller","year":"2010","unstructured":"Muller HL. Childhood craniopharyngioma\u2013current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol. 2010;6(11):609\u201318. https:\/\/doi.org\/10.1038\/nrendo.2010.168.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"9972_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3171\/jns.1998.89.4.0547","volume":"89","author":"GR Bunin","year":"1998","unstructured":"Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89(4):547\u201351. https:\/\/doi.org\/10.3171\/jns.1998.89.4.0547.","journal-title":"J Neurosurg"},{"issue":"8","key":"9972_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/neuonc\/nos142","volume":"14","author":"BE Zacharia","year":"2012","unstructured":"Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN. Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro Oncol. 2012;14(8):1070\u20138. https:\/\/doi.org\/10.1093\/neuonc\/nos142.","journal-title":"Neuro Oncol"},{"issue":"2","key":"9972_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ejendo\/lvae091","volume":"191","author":"D De Alcubierre","year":"2024","unstructured":"De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F, et al. BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. Eur J Endocrinol. 2024;191(2):251\u201361. https:\/\/doi.org\/10.1093\/ejendo\/lvae091.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"9972_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1210\/jc.2011-2817","volume":"97","author":"A Gautier","year":"2012","unstructured":"Gautier A, Godbout A, Grosheny C, Tejedor I, Coudert M, Courtillot C, et al. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab. 2012;97(4):1258\u201367. https:\/\/doi.org\/10.1210\/jc.2011-2817.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9972_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","volume":"62","author":"AM Pereira","year":"2005","unstructured":"Pereira AM, Schmid EM, Schutte PJ, Voormolen JH, Biermasz NR, van Thiel SW, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf). 2005;62(2):197\u2013204. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02196.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"9972_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11060-010-0145-5","volume":"100","author":"J Visser","year":"2010","unstructured":"Visser J, Hukin J, Sargent M, Steinbok P, Goddard K, Fryer C. Late mortality in pediatric patients with craniopharyngioma. J Neurooncol. 2010;100(1):105\u201311. https:\/\/doi.org\/10.1007\/s11060-010-0145-5.","journal-title":"J Neurooncol"},{"issue":"1","key":"9972_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1530\/EJE-17-0707","volume":"178","author":"M Wijnen","year":"2018","unstructured":"Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen J, van der Lely AJ, et al. Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol. 2018;178(1):93\u2013102. https:\/\/doi.org\/10.1530\/EJE-17-0707.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9972_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1530\/EJE-17-0044","volume":"176","author":"M Wijnen","year":"2017","unstructured":"Wijnen M, van den Heuvel-Eibrink MM, Janssen J, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, et al. Very long-term sequelae of craniopharyngioma. Eur J Endocrinol. 2017;176(6):755\u201367. https:\/\/doi.org\/10.1530\/EJE-17-0044.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"9972_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/er.2013-1115","volume":"35","author":"HL Muller","year":"2014","unstructured":"Muller HL. Craniopharyngioma. Endocr Rev. 2014;35(3):513\u201343. https:\/\/doi.org\/10.1210\/er.2013-1115.","journal-title":"Endocr Rev"},{"issue":"1","key":"9972_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40618-022-01900-9","volume":"46","author":"T Feola","year":"2023","unstructured":"Feola T, Pirchio RS, Puliani G, Pofi R, Crocco M, Sada V, et al. Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study. J Endocrinol Invest. 2023;46(1):181\u20138. https:\/\/doi.org\/10.1007\/s40618-022-01900-9.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"9972_CR12","doi-asserted-by":"publisher","first-page":"e12995","DOI":"10.1111\/jne.12995","volume":"33","author":"E Sbardella","year":"2021","unstructured":"Sbardella E, Puliani G, Feola T, Pofi R, Pirchio R, Sesti F, et al. A clinical approach to parasellar lesions in the transition age. J Neuroendocrinol. 2021;33(6):e12995. https:\/\/doi.org\/10.1111\/jne.12995.","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"9972_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrendo.2016.217","volume":"13","author":"HL Muller","year":"2017","unstructured":"Muller HL, Merchant TE, Puget S, Martinez-Barbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol. 2017;13(5):299\u2013312. https:\/\/doi.org\/10.1038\/nrendo.2016.217.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"9972_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11102-016-0751-0","volume":"20","author":"HL Muller","year":"2017","unstructured":"Muller HL. Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary. 2017;20(2):267\u201381. https:\/\/doi.org\/10.1007\/s11102-016-0751-0.","journal-title":"Pituitary"},{"issue":"6","key":"9972_CR15","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1210\/jc.2012-3928","volume":"98","author":"E Elowe-Gruau","year":"2013","unstructured":"Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C, et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab. 2013;98(6):2376\u201382. https:\/\/doi.org\/10.1210\/jc.2012-3928.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9972_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2265.2011.04172.x","volume":"76","author":"S Qi","year":"2012","unstructured":"Qi S, Pan J, Lu Y, Gao F, Cao Y, Peng J, et al. The impact of the site of origin and rate of tumour growth on clinical outcome in children with craniopharyngiomas. Clin Endocrinol (Oxf). 2012;76(1):103\u201310. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04172.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"9972_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijrobp.2014.05.051","volume":"90","author":"AJ Bishop","year":"2014","unstructured":"Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014;90(2):354\u201361. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.05.051.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"9972_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0360-3016(93)90227-m","volume":"27","author":"S Hetelekidis","year":"1993","unstructured":"Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, et al. 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 1993;27(2):189\u201395. https:\/\/doi.org\/10.1016\/0360-3016(93)90227-m.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"9972_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.braindev.2007.07.011","volume":"30","author":"YY Lee","year":"2008","unstructured":"Lee YY, Wong TT, Fang YT, Chang KP, Chen YW, Niu DM. Comparison of hypothalamopituitary axis dysfunction of intrasellar and third ventricular craniopharyngiomas in children. Brain Dev. 2008;30(3):189\u201394. https:\/\/doi.org\/10.1016\/j.braindev.2007.07.011.","journal-title":"Brain Dev"},{"key":"9972_CR20","doi-asserted-by":"publisher","unstructured":"Indelicato DJ, Bradley JA, Sandler ES, Aldana PR, Sapp A, Gains JE, et al. Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas. Pediatr Blood Cancer. 2017;64(12). https:\/\/doi.org\/10.1002\/pbc.26654.","DOI":"10.1002\/pbc.26654"},{"key":"9972_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13052-014-0074-6","volume":"40","author":"B Rombi","year":"2014","unstructured":"Rombi B, Vennarini S, Vinante L, Ravanelli D, Amichetti M. Proton radiotherapy for pediatric tumors: review of first clinical results. Ital J Pediatr. 2014;40:74. https:\/\/doi.org\/10.1186\/s13052-014-0074-6.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"9972_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijrobp.2024.03.015","volume":"120","author":"M Bischoff","year":"2024","unstructured":"Bischoff M, Khalil DA, Frisch S, Backer CM, Peters S, Friedrich C, et al. Outcome after modern proton beam therapy in childhood craniopharyngioma: results of the prospective registry study KiProReg. Int J Radiat Oncol Biol Phys. 2024;120(1):137\u201348. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.03.015.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"9972_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/cen.14334","volume":"94","author":"Z Hussein","year":"2021","unstructured":"Hussein Z, Glynn N, Martin N, Alkrekshi A, Mendoza N, Nair R, et al. Temporal trends in craniopharyngioma management and long-term endocrine outcomes: A multicentre cross-sectional study. Clin Endocrinol (Oxf). 2021;94(2):242\u20139. https:\/\/doi.org\/10.1111\/cen.14334.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"9972_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1515\/jpem.2001.14.7.869","volume":"14","author":"B Bin-Abbas","year":"2001","unstructured":"Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A. Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab. 2001;14(7):869\u201374. https:\/\/doi.org\/10.1515\/jpem.2001.14.7.869.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"9972_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12020-016-1196-y","volume":"58","author":"F Ferrau","year":"2017","unstructured":"Ferrau F, Spagnolo F, Cotta OR, Cannavo L, Alibrandi A, Russo GT, et al. Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma. Endocrine. 2017;58(2):295\u2013302. https:\/\/doi.org\/10.1007\/s12020-016-1196-y.","journal-title":"Endocrine"},{"issue":"3","key":"9972_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000079852","volume":"40","author":"EN Gonc","year":"2004","unstructured":"Gonc EN, Yordam N, Ozon A, Alikasifoglu A, Kandemir N. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases. Pediatr Neurosurg. 2004;40(3):112\u20139. https:\/\/doi.org\/10.1159\/000079852.","journal-title":"Pediatr Neurosurg"},{"issue":"5","key":"9972_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1530\/EJE-09-0449","volume":"161","author":"H Holmer","year":"2009","unstructured":"Holmer H, Ekman B, Bjork J, Nordstom CH, Popovic V, Siversson A, et al. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol. 2009;161(5):671\u20139. https:\/\/doi.org\/10.1530\/EJE-09-0449.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9972_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pedneo.2020.08.014","volume":"62","author":"CC Huang","year":"2021","unstructured":"Huang CC, Lin KL, Wu CT, Jung SM, Wang CJ, Chen YC, et al. Clinical and endocrinological manifestations of childhood-onset craniopharyngioma before surgical removal: a report from one medical center in Taiwan. Pediatr Neonatol. 2021;62(2):181\u20136. https:\/\/doi.org\/10.1016\/j.pedneo.2020.08.014.","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"9972_CR29","doi-asserted-by":"publisher","first-page":"e0246789","DOI":"10.1371\/journal.pone.0246789","volume":"16","author":"HW Jung","year":"2021","unstructured":"Jung HW, Kim HY, Kim JY, Cheon JE, Kim IO, Kim SK, et al. Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma. PLoS ONE. 2021;16(2):e0246789. https:\/\/doi.org\/10.1371\/journal.pone.0246789.","journal-title":"PLoS ONE"},{"issue":"9","key":"9972_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00381-009-0931-6","volume":"25","author":"MA Kalina","year":"2009","unstructured":"Kalina MA, Skala-Zamorowska E, Kalina-Faska B, Malecka-Tendera E, Mandera M. Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician. Childs Nerv Syst. 2009;25(9):1053\u201360. https:\/\/doi.org\/10.1007\/s00381-009-0931-6.","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"9972_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1530\/eje.1.01877","volume":"152","author":"P Kendall-Taylor","year":"2005","unstructured":"Kendall-Taylor P, Jonsson PJ, Abs R, Erfurth EM, Koltowska-Haggstrom M, Price DA, et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol. 2005;152(4):557\u201367. https:\/\/doi.org\/10.1530\/eje.1.01877.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"9972_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-2001-16855","volume":"213","author":"HL Muller","year":"2001","unstructured":"Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, et al. Obesity after childhood craniopharyngioma\u2013German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr. 2001;213(4):244\u20139. https:\/\/doi.org\/10.1055\/s-2001-16855.","journal-title":"Klin Padiatr"},{"issue":"7","key":"9972_CR33","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1210\/jc.2003-031751","volume":"89","author":"HL Muller","year":"2004","unstructured":"Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89(7):3298\u2013305. https:\/\/doi.org\/10.1210\/jc.2003-031751.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9972_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/EJE-11-0158","volume":"165","author":"HL Muller","year":"2011","unstructured":"Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol. 2011;165(1):17\u201324. https:\/\/doi.org\/10.1530\/EJE-11-0158.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9972_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1515\/jpem.2006.19.1.15","volume":"19","author":"CC Pedreira","year":"2006","unstructured":"Pedreira CC, Stargatt R, Maroulis H, Rosenfeld J, Maixner W, Warne GL, et al. Health related quality of life and psychological outcome in patients treated for craniopharyngioma in childhood. J Pediatr Endocrinol Metab. 2006;19(1):15\u201324. https:\/\/doi.org\/10.1515\/jpem.2006.19.1.15.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"9972_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00701-020-04591-4","volume":"163","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Chacko SR, Korula S, Simon A, Mathai S, Chacko G, et al. Long-term outcomes following maximal safe resection in a contemporary series of childhood craniopharyngiomas. Acta Neurochir (Wien). 2021;163(2):499\u2013509. https:\/\/doi.org\/10.1007\/s00701-020-04591-4.","journal-title":"Acta Neurochir (Wien)"},{"issue":"8\u20139","key":"9972_CR37","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00381-005-1225-2","volume":"21","author":"IJ Sosa","year":"2005","unstructured":"Sosa IJ, Krieger MD, McComb JG. Craniopharyngiomas of childhood: the CHLA experience. Childs Nerv Syst. 2005;21(8\u20139):785\u20139. https:\/\/doi.org\/10.1007\/s00381-005-1225-2.","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"9972_CR38","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s12020-021-02824-9","volume":"74","author":"D Svard","year":"2021","unstructured":"Svard D, Follin C, Fjalldal S, Hellerstedt R, Mannfolk P, Martensson J, et al. Cognitive interference processing in adults with childhood craniopharyngioma using functional magnetic resonance imaging. Endocrine. 2021;74(3):714\u201322. https:\/\/doi.org\/10.1007\/s12020-021-02824-9.","journal-title":"Endocrine"},{"issue":"1","key":"9972_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-17-0387","volume":"178","author":"M Wijnen","year":"2018","unstructured":"Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen J, van der Lely AJ, et al. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. Eur J Endocrinol. 2018;178(1):11\u201322. https:\/\/doi.org\/10.1530\/EJE-17-0387.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9972_CR40","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1210\/jc.2017-01542","volume":"103","author":"KCJ Yuen","year":"2018","unstructured":"Yuen KCJ, Mattsson AF, Burman P, Erfurth EM, Camacho-Hubner C, Fox JL, et al. Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement. J Clin Endocrinol Metab. 2018;103(2):768\u201377. https:\/\/doi.org\/10.1210\/jc.2017-01542.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9972_CR41","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1210\/clinem\/dgab784","volume":"107","author":"S Zucchini","year":"2022","unstructured":"Zucchini S, Di Iorgi N, Pozzobon G, Pedicelli S, Parpagnoli M, Driul D, et al. Management of childhood-onset craniopharyngioma in Italy: a multicenter, 7-year follow-up study of 145 patients. J Clin Endocrinol Metab. 2022;107(3):e1020\u201331. https:\/\/doi.org\/10.1210\/clinem\/dgab784.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9972_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-2004-832339","volume":"216","author":"HL Muller","year":"2004","unstructured":"Muller HL, Gebhardt U, Etavard-Gorris N, Korenke E, Warmuth-Metz M, Kolb R, et al. Prognosis and sequela in patients with childhood craniopharyngioma \u2013 results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin Padiatr. 2004;216(6):343\u20138. https:\/\/doi.org\/10.1055\/s-2004-832339.","journal-title":"Klin Padiatr"},{"issue":"1","key":"9972_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/jc.2003-030442","volume":"89","author":"S Srinivasan","year":"2004","unstructured":"Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89(1):81\u20136. https:\/\/doi.org\/10.1210\/jc.2003-030442.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9972_CR44","doi-asserted-by":"publisher","first-page":"P35","DOI":"10.1530\/EJE-21-1186","volume":"186","author":"MCS Boguszewski","year":"2022","unstructured":"Boguszewski MCS, Boguszewski CL, Chemaitilly W, Cohen LE, Gebauer J, Higham C, et al. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement. Eur J Endocrinol. 2022;186(6):P35\u201352. https:\/\/doi.org\/10.1530\/EJE-21-1186.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"9972_CR45","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1210\/jc.2018-00665","volume":"103","author":"JM Garcia","year":"2018","unstructured":"Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, et al. Macimorelin as a diagnostic test for adult GH deficiency. J Clin Endocrinol Metab. 2018;103(8):3083\u201393. https:\/\/doi.org\/10.1210\/jc.2018-00665.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9972_CR46","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1210\/jcem.87.6.8546","volume":"87","author":"M Maghnie","year":"2002","unstructured":"Maghnie M, Cavigioli F, Tinelli C, Autelli M, Arico M, Aimaretti G, et al. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. J Clin Endocrinol Metab. 2002;87(6):2740\u20134. https:\/\/doi.org\/10.1210\/jcem.87.6.8546.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9972_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86(6):361\u201397. https:\/\/doi.org\/10.1159\/000452150.","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"9972_CR48","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1210\/jcem.84.4.5614","volume":"84","author":"M Maghnie","year":"1999","unstructured":"Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, et al. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab. 1999;84(4):1324\u20138. https:\/\/doi.org\/10.1210\/jcem.84.4.5614.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9972_CR49","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s10072-015-2269-z","volume":"36","author":"L Shen","year":"2015","unstructured":"Shen L, Sun CM, Li XT, Liu CJ, Zhou YX. Growth hormone therapy and risk of recurrence\/progression in intracranial tumors: a meta-analysis. Neurol Sci. 2015;36(10):1859\u201367. https:\/\/doi.org\/10.1007\/s10072-015-2269-z.","journal-title":"Neurol Sci"},{"issue":"8","key":"9972_CR50","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/clinem\/dgad079","volume":"108","author":"A Nguyen Quoc","year":"2023","unstructured":"Nguyen Quoc A, Beccaria K, Gonzalez Briceno L, Pinto G, Samara-Boustani D, Stoupa A, et al. GH and childhood-onset craniopharyngioma: when to initiate GH replacement therapy? J Clin Endocrinol Metab. 2023;108(8):1929\u201336. https:\/\/doi.org\/10.1210\/clinem\/dgad079.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9972_CR51","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s11102-020-01052-0","volume":"23","author":"E Sbardella","year":"2020","unstructured":"Sbardella E, Crocco M, Feola T, Papa F, Puliani G, Gianfrilli D, et al. GH deficiency in cancer survivors in the transition age: diagnosis and therapy. Pituitary. 2020;23(4):432\u201356. https:\/\/doi.org\/10.1007\/s11102-020-01052-0.","journal-title":"Pituitary"},{"key":"9972_CR52","doi-asserted-by":"publisher","unstructured":"van Iersel L, van Schaik J, van Santen HM. Growth hormone replacement therapy in childhood-onset craniopharyngioma. Best Pract Res Clin Endocrinol Metab. 2025;101998. https:\/\/doi.org\/10.1016\/j.beem.2025.101998.","DOI":"10.1016\/j.beem.2025.101998"},{"issue":"3","key":"9972_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000284358","volume":"73","author":"HL Muller","year":"2010","unstructured":"Muller HL, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A, et al. Analyses of treatment variables for patients with childhood craniopharyngioma\u2013results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr. 2010;73(3):175\u201380. https:\/\/doi.org\/10.1159\/000284358.","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"9972_CR54","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","volume":"64","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, et al. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2006;64(5):556\u201360. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02508.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"9972_CR55","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1530\/EJE-12-0077","volume":"166","author":"DS Olsson","year":"2012","unstructured":"Olsson DS, Buchfelder M, Wiendieck K, Kremenevskaja N, Bengtsson BA, Jakobsson KE, et al. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up. Eur J Endocrinol. 2012;166(6):1061\u20138. https:\/\/doi.org\/10.1530\/EJE-12-0077.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9972_CR56","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2265.2007.03135.x","volume":"68","author":"TT Chung","year":"2008","unstructured":"Chung TT, Evanson J, Walker D, Akker SA, Besser GM, Monson JP, et al. Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours. Clin Endocrinol (Oxf). 2008;68(6):965\u20139. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03135.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9972_CR57","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae834","author":"A Maniatis","year":"2024","unstructured":"Maniatis A, Cutfield W, Dattani M, Deal C, Collett-Solberg PF, Horikawa R, et al. Long-acting growth hormone therapy in pediatric growth hormone deficiency: a consensus statement. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae834.","journal-title":"J Clin Endocrinol Metab"},{"key":"9972_CR58","doi-asserted-by":"publisher","first-page":"737743","DOI":"10.3389\/fneur.2021.737743","volume":"12","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Zhang S, Hu F. Endocrine disorder in patients with craniopharyngioma. Front Neurol. 2021;12:737743. https:\/\/doi.org\/10.3389\/fneur.2021.737743.","journal-title":"Front Neurol"},{"issue":"6","key":"9972_CR59","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1210\/clinem\/dgac054","volume":"107","author":"J Harrington","year":"2022","unstructured":"Harrington J, Palmert MR. An approach to the patient with delayed puberty. J Clin Endocrinol Metab. 2022;107(6):1739\u201350. https:\/\/doi.org\/10.1210\/clinem\/dgac054.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9972_CR60","doi-asserted-by":"publisher","first-page":"e2156","DOI":"10.1210\/clinem\/dgab893","volume":"107","author":"LG Gonzalez Briceno","year":"2022","unstructured":"Gonzalez Briceno LG, Kariyawasam D, Samara-Boustani D, Giani E, Beltrand J, Bolle S, et al. High prevalence of early endocrine disorders after childhood brain tumors in a large cohort. J Clin Endocrinol Metab. 2022;107(5):e2156\u201366. https:\/\/doi.org\/10.1210\/clinem\/dgab893.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9972_CR61","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4103\/0028-3886.344661","volume":"70","author":"GS Harsha","year":"2022","unstructured":"Harsha GS, Dabadghao P, Sudhanshu S. Long-term outcomes of paediatric-onset craniopharyngioma: a retrospective analysis from a tertiary care centre in North India. Neurol India. 2022;70(2):600\u20135. https:\/\/doi.org\/10.4103\/0028-3886.344661.","journal-title":"Neurol India"},{"issue":"9","key":"9972_CR62","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1210\/clinem\/dgad097","volume":"108","author":"M Rosimont","year":"2023","unstructured":"Rosimont M, Kariyawasam D, Samara-Boustani D, Giani E, Beltrand J, Bolle S, et al. Assessment of puberty and hypothalamic-pituitary-gonadal axis function after childhood brain tumor treatment. J Clin Endocrinol Metab. 2023;108(9):e823\u201331. https:\/\/doi.org\/10.1210\/clinem\/dgad097.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9972_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1530\/EJE-11-0229","volume":"165","author":"H Holmer","year":"2011","unstructured":"Holmer H, Popovic V, Ekman B, Follin C, Siversson AB, Erfurth EM. Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma. Eur J Endocrinol. 2011;165(1):25\u201331. https:\/\/doi.org\/10.1530\/EJE-11-0229.","journal-title":"Eur J Endocrinol"},{"key":"9972_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coemr.2020.04.003","volume":"14","author":"AA Dwyer","year":"2020","unstructured":"Dwyer AA. Psychosexual effects resulting from delayed, incomplete, or absent puberty. Curr Opin Endocr Metab Res. 2020;14:15\u201321. https:\/\/doi.org\/10.1016\/j.coemr.2020.04.003.","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"6","key":"9972_CR65","doi-asserted-by":"publisher","first-page":"G9","DOI":"10.1530\/EJE-22-0073","volume":"186","author":"A Nordenstrom","year":"2022","unstructured":"Nordenstrom A, Ahmed SF, van den Akker E, Blair J, Bonomi M, Brachet C, et al. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline. Eur J Endocrinol. 2022;186(6):G9\u201349. https:\/\/doi.org\/10.1530\/EJE-22-0073.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9972_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1159\/000499929","volume":"28","author":"N Khawaja","year":"2019","unstructured":"Khawaja N, Owaineh H, Batieha A, Frahid O, El-Khateeb M, Ajlouni KM. The effect of gonadotropin-releasing hormone analogue on final adult height in children with idiopathic short stature. Med Princ Pract. 2019;28(6):509\u201316. https:\/\/doi.org\/10.1159\/000499929.","journal-title":"Med Princ Pract"},{"issue":"5","key":"9972_CR67","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1210\/jc.2016-1317","volume":"101","author":"M van der Steen","year":"2016","unstructured":"van der Steen M, Lem AJ, van der Kaay DC, Hokken-Koeelega AC. Puberty and pubertal growth in GH-treated SGA children: effects of 2 years of GnRHa versus No GnRHa. J Clin Endocrinol Metab. 2016;101(5):2005\u201312. https:\/\/doi.org\/10.1210\/jc.2016-1317.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9972_CR68","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/ejendo\/lvad166","volume":"190","author":"EC Alexander","year":"2024","unstructured":"Alexander EC, Faruqi D, Farquhar R, Unadkat A, Ng Yin K, Hoskyns R, et al. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis. Eur J Endocrinol. 2024;190(1):S1\u201311. https:\/\/doi.org\/10.1093\/ejendo\/lvad166.","journal-title":"Eur J Endocrinol"},{"issue":"8\u20139","key":"9972_CR69","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00381-005-1201-x","volume":"21","author":"G Zuccaro","year":"2005","unstructured":"Zuccaro G. Radical resection of craniopharyngioma. Childs Nerv Syst. 2005;21(8\u20139):679\u201390. https:\/\/doi.org\/10.1007\/s00381-005-1201-x.","journal-title":"Childs Nerv Syst"},{"issue":"11","key":"9972_CR70","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888\u2013921. https:\/\/doi.org\/10.1210\/jc.2016-2118.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9972_CR71","doi-asserted-by":"publisher","first-page":"541","DOI":"10.20945\/2359-3997000000493","volume":"66","author":"MR Bitencourt","year":"2022","unstructured":"Bitencourt MR, Batista RL, Biscotto I, Carvalho LR. Central adrenal insufficiency: who, when, and how? From the evidence to the controversies - an exploratory review. Arch Endocrinol Metab. 2022;66(4):541\u201350. https:\/\/doi.org\/10.20945\/2359-3997000000493.","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"9972_CR72","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1210\/jc.2013-4253","volume":"99","author":"M Oksnes","year":"2014","unstructured":"Oksnes M, Bjornsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, et al. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison\u2019s disease: a randomized clinical trial. J Clin Endocrinol Metab. 2014;99(5):1665\u201374. https:\/\/doi.org\/10.1210\/jc.2013-4253.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9972_CR73","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1210\/jc.2008-2380","volume":"94","author":"M Debono","year":"2009","unstructured":"Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548\u201354. https:\/\/doi.org\/10.1210\/jc.2008-2380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9972_CR74","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","volume":"6","author":"AM Isidori","year":"2018","unstructured":"Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, et al. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2018;6(3):173\u201385. https:\/\/doi.org\/10.1016\/S2213-8587(17)30398-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"9972_CR75","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1210\/jc.2013-3631","volume":"99","author":"KC Yuen","year":"2014","unstructured":"Yuen KC, Koltowska-Haggstrom M, Cook DM, Fox JL, Jonsson PJ, Geffner ME, et al. Primary treatment regimen and diabetes insipidus as predictors of health outcomes in adults with childhood-onset craniopharyngioma. J Clin Endocrinol Metab. 2014;99(4):1227\u201335. https:\/\/doi.org\/10.1210\/jc.2013-3631.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9972_CR76","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/oby.23087","volume":"29","author":"DC Emet","year":"2021","unstructured":"Emet DC, Ozon A, Alikasifoglu A, Kandemir N, Gonc N. Alpha-melanocyte-stimulating hormone is elevated in hypothalamic obesity associated with childhood craniopharyngioma. Obesity (Silver Spring). 2021;29(2):402\u20138. https:\/\/doi.org\/10.1002\/oby.23087.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"9972_CR77","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/ejendo\/lvae084","volume":"191","author":"A Fountas","year":"2024","unstructured":"Fountas A, Coulden A, Fernandez-Garcia S, Tsermoulas G, Allotey J, Karavitaki N. Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: a systematic review and meta-analysis. Eur J Endocrinol. 2024;191(1):S1\u201313. https:\/\/doi.org\/10.1093\/ejendo\/lvae084.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9972_CR78","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000324115","volume":"76","author":"MJ Finken","year":"2011","unstructured":"Finken MJ, Zwaveling-Soonawala N, Walenkamp MJ, Vulsma T, van Trotsenburg AS, Rotteveel J. Frequent occurrence of the triphasic response (diabetes insipidus\/hyponatremia\/diabetes insipidus) after surgery for craniopharyngioma in childhood. Horm Res Paediatr. 2011;76(1):22\u20136. https:\/\/doi.org\/10.1159\/000324115.","journal-title":"Horm Res Paediatr"},{"issue":"8\u20139","key":"9972_CR79","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00381-005-1202-9","volume":"21","author":"T Tomita","year":"2005","unstructured":"Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at Children\u2019s memorial hospital. Childs Nerv Syst. 2005;21(8\u20139):729\u201346. https:\/\/doi.org\/10.1007\/s00381-005-1202-9.","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"9972_CR80","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1530-0277.1995.tb01579.x","volume":"19","author":"H Taivainen","year":"1995","unstructured":"Taivainen H, Laitinen K, Tahtela R, Kilanmaa K, Valimaki MJ. Role of plasma vasopressin in changes of water balance accompanying acute alcohol intoxication. Alcohol Clin Exp Res. 1995;19(3):759\u201362. https:\/\/doi.org\/10.1111\/j.1530-0277.1995.tb01579.x.","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"9972_CR81","doi-asserted-by":"publisher","first-page":"R522","DOI":"10.1152\/ajpregu.1982.242.5.R522","volume":"242","author":"G Eisenhofer","year":"1982","unstructured":"Eisenhofer G, Johnson RH. Effect of ethanol ingestion on plasma vasopressin and water balance in humans. Am J Physiol. 1982;242(5):R522\u20137. https:\/\/doi.org\/10.1152\/ajpregu.1982.242.5.R522.","journal-title":"Am J Physiol"},{"issue":"1\u20132","key":"9972_CR82","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/0006-8993(91)90954-t","volume":"551","author":"XM Wang","year":"1991","unstructured":"Wang XM, Lemos JR, Dayanithi G, Nordmann JJ, Treistman SN. Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals. Brain Res. 1991;551(1\u20132):338\u201341. https:\/\/doi.org\/10.1016\/0006-8993(91)90954-t.","journal-title":"Brain Res"},{"issue":"4","key":"9972_CR83","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaac.2021.12.001","volume":"61","author":"KS Bagot","year":"2022","unstructured":"Bagot KS. Editorial: durability of alcohol use prevention effects in adolescents and transitional age youth. J Am Acad Child Adolesc Psychiatry. 2022;61(4):473\u20135. https:\/\/doi.org\/10.1016\/j.jaac.2021.12.001.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9\u201310","key":"9972_CR84","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1159\/000509616","volume":"110","author":"EM Erfurth","year":"2020","unstructured":"Erfurth EM. Diagnosis, background, and treatment of hypothalamic damage in Craniopharyngioma. Neuroendocrinology. 2020;110(9\u201310):767\u201379. https:\/\/doi.org\/10.1159\/000509616.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"9972_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","volume":"8","author":"HL Muller","year":"2022","unstructured":"Muller HL, Tauber M, Lawson EA, Ozyurt J, Bison B, Martinez-Barbera JP, et al. Hypothalamic syndrome. Nat Rev Dis Primers. 2022;8(1):24. https:\/\/doi.org\/10.1038\/s41572-022-00351-z.","journal-title":"Nat Rev Dis Primers"},{"key":"9972_CR86","doi-asserted-by":"publisher","unstructured":"van Santen HM, van Schaik J, van Roessel I, Beckhaus J, Boekhoff S, Muller HL. Diagnostic criteria for the hypothalamic syndrome in childhood. Eur J Endocrinol. 2023;188(2). https:\/\/doi.org\/10.1093\/ejendo\/lvad009.","DOI":"10.1093\/ejendo\/lvad009"},{"issue":"Suppl 2","key":"9972_CR87","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dom.15530","volume":"26","author":"CL Roth","year":"2024","unstructured":"Roth CL, McCormack SE. Acquired hypothalamic obesity: a clinical overview and update. Diabetes Obes Metab. 2024;26(Suppl 2):34\u201345. https:\/\/doi.org\/10.1111\/dom.15530.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"9972_CR88","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1210\/en.2010-0336","volume":"151","author":"JP Thaler","year":"2010","unstructured":"Thaler JP, Schwartz MW. Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology. 2010;151(9):4109\u201315. https:\/\/doi.org\/10.1210\/en.2010-0336.","journal-title":"Endocrinology"},{"issue":"1","key":"9972_CR89","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11102-012-0401-0","volume":"16","author":"HL Muller","year":"2013","unstructured":"Muller HL. Childhood craniopharyngioma. Pituitary. 2013;16(1):56\u201367. https:\/\/doi.org\/10.1007\/s11102-012-0401-0.","journal-title":"Pituitary"},{"issue":"10","key":"9972_CR90","doi-asserted-by":"publisher","first-page":"e3820","DOI":"10.1210\/clinem\/dgab397","volume":"106","author":"A Otte","year":"2021","unstructured":"Otte A, Muller HL. Childhood-onset Craniopharyngioma. J Clin Endocrinol Metab. 2021;106(10):e3820\u201336. https:\/\/doi.org\/10.1210\/clinem\/dgab397.","journal-title":"J Clin Endocrinol Metab"},{"key":"9972_CR91","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fendo.2011.00049","volume":"2","author":"CL Roth","year":"2011","unstructured":"Roth CL. Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits. Front Endocrinol (Lausanne). 2011;2:49. https:\/\/doi.org\/10.3389\/fendo.2011.00049.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1 Suppl","key":"9972_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/ped.2007.106.1.3","volume":"106","author":"S Puget","year":"2007","unstructured":"Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg. 2007;106(1 Suppl):3\u201312. https:\/\/doi.org\/10.3171\/ped.2007.106.1.3.","journal-title":"J Neurosurg"},{"issue":"8","key":"9972_CR93","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00381-012-1787-8","volume":"28","author":"C Mallucci","year":"2012","unstructured":"Mallucci C, Pizer B, Blair J, Didi M, Doss A, Upadrasta S, et al. Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system. Childs Nerv Syst. 2012;28(8):1181\u201392. https:\/\/doi.org\/10.1007\/s00381-012-1787-8.","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"9972_CR94","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10552-005-9012-7","volume":"17","author":"HL Muller","year":"2006","unstructured":"Muller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R, et al. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control. 2006;17(4):583\u20139. https:\/\/doi.org\/10.1007\/s10552-005-9012-7.","journal-title":"Cancer Causes Control"},{"issue":"1\u20132","key":"9972_CR95","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/jpem-2014-0415","volume":"28","author":"A Hoffmann","year":"2015","unstructured":"Hoffmann A, Postma FP, Sterkenburg AS, Gebhardt U, Muller HL. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma. J Pediatr Endocrinol Metab. 2015;28(1\u20132):35\u201343. https:\/\/doi.org\/10.1515\/jpem-2014-0415.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"9972_CR96","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF03344156","volume":"29","author":"E Cacciari","year":"2006","unstructured":"Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest. 2006;29(7):581\u201393. https:\/\/doi.org\/10.1007\/BF03344156.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"9972_CR97","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jpc.12190","volume":"49","author":"SR Rath","year":"2013","unstructured":"Rath SR, Lee S, Kotecha RS, Taylor M, Junckerstorff RC, Choong CS. Childhood craniopharyngioma: 20-year institutional experience in Western Australia. J Paediatr Child Health. 2013;49(5):403\u20138. https:\/\/doi.org\/10.1111\/jpc.12190.","journal-title":"J Paediatr Child Health"},{"issue":"7","key":"9972_CR98","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/neuonc\/nov044","volume":"17","author":"AS Sterkenburg","year":"2015","unstructured":"Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM, Muller HL. Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol. 2015;17(7):1029\u201338. https:\/\/doi.org\/10.1093\/neuonc\/nov044.","journal-title":"Neuro Oncol"},{"issue":"7","key":"9972_CR99","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jcem.81.7.8675604","volume":"81","author":"CJ de Vile","year":"1996","unstructured":"de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab. 1996;81(7):2734\u20137. https:\/\/doi.org\/10.1210\/jcem.81.7.8675604.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9972_CR100","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1055\/s-2003-45499","volume":"215","author":"HL Muller","year":"2003","unstructured":"Muller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, et al. Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr. 2003;215(6):310\u20134. https:\/\/doi.org\/10.1055\/s-2003-45499.","journal-title":"Klin Padiatr"},{"issue":"1","key":"9972_CR101","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000507702","volume":"93","author":"S Jazbinsek","year":"2020","unstructured":"Jazbinsek S, Kolenc D, Bosnjak R, Faganel Kotnik B, Zadravec Zaletel L, Jenko Bizjan B, et al. Prevalence of endocrine and metabolic comorbidities in a national cohort of patients with craniopharyngioma. Horm Res Paediatr. 2020;93(1):46\u201357. https:\/\/doi.org\/10.1159\/000507702.","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"9972_CR102","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1210\/jc.2010-0993","volume":"95","author":"H Holmer","year":"2010","unstructured":"Holmer H, Pozarek G, Wirfalt E, Popovic V, Ekman B, Bjork J, et al. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab. 2010;95(12):5395\u2013402. https:\/\/doi.org\/10.1210\/jc.2010-0993.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"9972_CR103","doi-asserted-by":"publisher","first-page":"e12527","DOI":"10.1111\/ijpo.12527","volume":"14","author":"AM Daubenbuchel","year":"2019","unstructured":"Daubenbuchel AM, Ozyurt J, Boekhoff S, Warmuth-Metz M, Eveslage M, Muller HL. Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement. Pediatr Obes. 2019;14(9):e12527. https:\/\/doi.org\/10.1111\/ijpo.12527.","journal-title":"Pediatr Obes"},{"issue":"11","key":"9972_CR104","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1210\/jc.2002-021797","volume":"88","author":"KJ Harz","year":"2003","unstructured":"Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab. 2003;88(11):5227\u201331. https:\/\/doi.org\/10.1210\/jc.2002-021797.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9972_CR105","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00431-020-03915-x","volume":"180","author":"P Sowithayasakul","year":"2021","unstructured":"Sowithayasakul P, Buschmann LK, Boekhoff S, Muller HL. Cardiac remodeling in patients with childhood-onset craniopharyngioma-results of HIT-Endo and KRANIOPHARYNGEOM 2000\/2007. Eur J Pediatr. 2021;180(5):1593\u2013602. https:\/\/doi.org\/10.1007\/s00431-020-03915-x.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"9972_CR106","doi-asserted-by":"publisher","first-page":"107","DOI":"10.6065\/apem.2244046.023","volume":"28","author":"SH Park","year":"2023","unstructured":"Park SH, Lee YJ, Cheon JE, Shin CH, Jung HW, Lee YA. The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma. Ann Pediatr Endocrinol Metab. 2023;28(2):107\u201315. https:\/\/doi.org\/10.6065\/apem.2244046.023.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"3","key":"9972_CR107","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/02699052.2011.648709","volume":"26","author":"C Laffond","year":"2012","unstructured":"Laffond C, Dellatolas G, Alapetite C, Puget S, Grill J, Habrand JL, et al. Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj. 2012;26(3):270\u201381. https:\/\/doi.org\/10.3109\/02699052.2011.648709.","journal-title":"Brain Inj"},{"issue":"8\u20139","key":"9972_CR108","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00381-005-1210-9","volume":"21","author":"D Thompson","year":"2005","unstructured":"Thompson D, Phipps K, Hayward R. Craniopharyngioma in childhood: our evidence-based approach to management. Childs Nerv Syst. 2005;21(8\u20139):660\u20138. https:\/\/doi.org\/10.1007\/s00381-005-1210-9.","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"9972_CR109","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41366-018-0185-z","volume":"43","author":"S Fjalldal","year":"2019","unstructured":"Fjalldal S, Follin C, Gabery S, Sundgren PC, Bjorkman-Burtscher IM, Latt J, et al. Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. Int J Obes (Lond). 2019;43(3):533\u201344. https:\/\/doi.org\/10.1038\/s41366-018-0185-z.","journal-title":"Int J Obes (Lond)"},{"issue":"5\u20136","key":"9972_CR110","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1515\/jpem-2014-0512","volume":"28","author":"B Haliloglu","year":"2015","unstructured":"Haliloglu B, Bereket A. Hypothalamic obesity in children: pathophysiology to clinical management. J Pediatr Endocrinol Metab. 2015;28(5\u20136):503\u201313. https:\/\/doi.org\/10.1515\/jpem-2014-0512.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"9972_CR111","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12020-017-1489-9","volume":"59","author":"K Heinks","year":"2018","unstructured":"Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, et al. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine. 2018;59(2):364\u201372. https:\/\/doi.org\/10.1007\/s12020-017-1489-9.","journal-title":"Endocrine"},{"issue":"5","key":"9972_CR112","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/EJE-18-0505","volume":"179","author":"S Boekhoff","year":"2018","unstructured":"Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Muller HL. Long-term effects of growth hormone replacement therapy in childhood-onset Craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo). Eur J Endocrinol. 2018;179(5):331\u201341. https:\/\/doi.org\/10.1530\/EJE-18-0505.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"9972_CR113","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1055\/a-0641-5956","volume":"50","author":"PDC Tosta-Hernandez","year":"2018","unstructured":"Tosta-Hernandez PDC, Siviero-Miachon AA, da Silva NS, Cappellano A, Pinheiro MM, Spinola-Castro AM. Childhood craniopharyngioma: a 22-year challenging follow-up in a single center. Horm Metab Res. 2018;50(9):675\u201382. https:\/\/doi.org\/10.1055\/a-0641-5956.","journal-title":"Horm Metab Res"},{"issue":"7","key":"9972_CR114","doi-asserted-by":"publisher","first-page":"e28379","DOI":"10.1002\/pbc.28379","volume":"67","author":"VE Horne","year":"2020","unstructured":"Horne VE, Bielamowicz K, Nguyen J, Hilsenbeck S, Lindsay H, Sonabend R, et al. Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity. Pediatr Blood Cancer. 2020;67(7):e28379. https:\/\/doi.org\/10.1002\/pbc.28379.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"9972_CR115","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1530\/EJE-12-0997","volume":"168","author":"F Zoicas","year":"2013","unstructured":"Zoicas F, Droste M, Mayr B, Buchfelder M, Schofl C. GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases. Eur J Endocrinol. 2013;168(5):699\u2013706. https:\/\/doi.org\/10.1530\/EJE-12-0997.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9972_CR116","doi-asserted-by":"publisher","first-page":"bvae200","DOI":"10.1210\/jendso\/bvae200","volume":"9","author":"P Dimitri","year":"2024","unstructured":"Dimitri P, Roth CL. Treatment of hypothalamic obesity With GLP-1 analogs. J Endocr Soc. 2024;9(1):bvae200. https:\/\/doi.org\/10.1210\/jendso\/bvae200.","journal-title":"J Endocr Soc"},{"issue":"5","key":"9972_CR117","doi-asserted-by":"publisher","first-page":"bvad037","DOI":"10.1210\/jendso\/bvad037","volume":"7","author":"SE McCormack","year":"2023","unstructured":"McCormack SE, Wang Z, Wade KL, Dedio A, Cilenti N, Crowley J, et al. A pilot randomized clinical trial of intranasal oxytocin to promote weight loss in individuals with hypothalamic obesity. J Endocr Soc. 2023;7(5):bvad037. https:\/\/doi.org\/10.1210\/jendso\/bvad037.","journal-title":"J Endocr Soc"},{"key":"9972_CR118","doi-asserted-by":"publisher","first-page":"1307889","DOI":"10.3389\/fendo.2023.1307889","volume":"14","author":"HM van Santen","year":"2023","unstructured":"van Santen HM, Denzer C, Muller HL. Could setmelanotide be the game-changer for acquired hypothalamic obesity? Front Endocrinol (Lausanne). 2023;14:1307889. https:\/\/doi.org\/10.3389\/fendo.2023.1307889.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"9972_CR119","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","volume":"12","author":"CL Roth","year":"2024","unstructured":"Roth CL, Scimia C, Shoemaker AH, Gottschalk M, Miller J, Yuan G, et al. Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. Lancet Diabetes Endocrinol. 2024;12(6):380\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(24)00087-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"9972_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/EJE-09-0079","volume":"161","author":"B Schultes","year":"2009","unstructured":"Schultes B, Ernst B, Schmid F, Thurnheer M. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur J Endocrinol. 2009;161(1):201\u20136. https:\/\/doi.org\/10.1530\/EJE-09-0079.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9972_CR121","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1055\/s-0031-1284420","volume":"223","author":"HL Muller","year":"2011","unstructured":"Muller HL, Gebhardt U, Maroske J, Hanisch E. Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin Padiatr. 2011;223(6):372\u20133. https:\/\/doi.org\/10.1055\/s-0031-1284420.","journal-title":"Klin Padiatr"},{"issue":"3","key":"9972_CR122","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2265.2012.04409.x","volume":"78","author":"D Weismann","year":"2013","unstructured":"Weismann D, Pelka T, Bender G, Jurowich C, Fassnacht M, Thalheimer A, et al. Bariatric surgery for morbid obesity in craniopharyngioma. Clin Endocrinol (Oxf). 2013;78(3):385\u201390. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04409.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"9972_CR123","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1210\/jc.2012-4184","volume":"98","author":"M Bretault","year":"2013","unstructured":"Bretault M, Boillot A, Muzard L, Poitou C, Oppert JM, Barsamian C, et al. Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab. 2013;98(6):2239\u201346. https:\/\/doi.org\/10.1210\/jc.2012-4184.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6669","key":"9972_CR124","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.adh8285","volume":"382","author":"AR Adamantidis","year":"2023","unstructured":"Adamantidis AR, de Lecea L. Sleep and the hypothalamus. Science. 2023;382(6669):405\u201312. https:\/\/doi.org\/10.1126\/science.adh8285.","journal-title":"Science"},{"key":"9972_CR125","doi-asserted-by":"publisher","first-page":"817257","DOI":"10.3389\/fneur.2021.817257","volume":"12","author":"A Romigi","year":"2021","unstructured":"Romigi A, Feola T, Cappellano S, De Angelis M, Pio G, Caccamo M, et al. Sleep disorders in patients with craniopharyngioma: a physiopathological and practical update. Front Neurol. 2021;12:817257. https:\/\/doi.org\/10.3389\/fneur.2021.817257.","journal-title":"Front Neurol"},{"issue":"5","key":"9972_CR126","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387\u201394. https:\/\/doi.org\/10.1378\/chest.14-0970.","journal-title":"Chest"},{"issue":"3","key":"9972_CR127","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11060-012-0859-7","volume":"108","author":"PE Manley","year":"2012","unstructured":"Manley PE, McKendrick K, McGillicudy M, Chi SN, Kieran MW, Cohen LE, et al. Sleep dysfunction in long term survivors of craniopharyngioma. J Neurooncol. 2012;108(3):543\u20139. https:\/\/doi.org\/10.1007\/s11060-012-0859-7.","journal-title":"J Neurooncol"},{"issue":"5","key":"9972_CR128","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1210\/jc.2009-2003","volume":"95","author":"CS O'Gorman","year":"2010","unstructured":"O\u2019Gorman CS, Simoneau-Roy J, Pencharz P, MacFarlane J, MacLusky I, Narang I, et al. Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls. J Clin Endocrinol Metab. 2010;95(5):2211\u20138. https:\/\/doi.org\/10.1210\/jc.2009-2003.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9972_CR129","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-020-03519-3","volume":"148","author":"BN Mandrell","year":"2020","unstructured":"Mandrell BN, LaRosa K, Hancock D, Caples M, Sykes A, Lu Z, et al. Predictors of narcolepsy and hypersomnia due to medical disorder in pediatric craniopharyngioma. J Neurooncol. 2020;148(2):307\u201316. https:\/\/doi.org\/10.1007\/s11060-020-03519-3.","journal-title":"J Neurooncol"},{"key":"9972_CR130","doi-asserted-by":"publisher","first-page":"876011","DOI":"10.3389\/fneur.2022.876011","volume":"13","author":"R Cordani","year":"2022","unstructured":"Cordani R, Veneruso M, Napoli F, Di Iorgi N, Milanaccio C, Consales A, et al. Sleep disturbances in pediatric craniopharyngioma: a systematic review. Front Neurol. 2022;13:876011. https:\/\/doi.org\/10.3389\/fneur.2022.876011.","journal-title":"Front Neurol"},{"issue":"4","key":"9972_CR131","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1212\/WNL.0b013e3181af78a5","volume":"73","author":"J Lipton","year":"2009","unstructured":"Lipton J, Megerian JT, Kothare SV, Cho YJ, Shanahan T, Chart H, et al. Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma. Neurology. 2009;73(4):323\u20135. https:\/\/doi.org\/10.1212\/WNL.0b013e3181af78a5.","journal-title":"Neurology"},{"issue":"6","key":"9972_CR132","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1530\/EJE-13-1025","volume":"170","author":"L Pickering","year":"2014","unstructured":"Pickering L, Jennum P, Gammeltoft S, Poulsgaard L, Feldt-Rasmussen U, Klose M. Sleep-wake and melatonin pattern in craniopharyngioma patients. Eur J Endocrinol. 2014;170(6):873\u201384. https:\/\/doi.org\/10.1530\/EJE-13-1025.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9972_CR133","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/jpepsy\/jsw026","volume":"41","author":"LM Jacola","year":"2016","unstructured":"Jacola LM, Conklin HM, Scoggins MA, Ashford JM, Merchant TE, Mandrell BN, et al. Investigating the role of hypothalamic tumor involvement in sleep and cognitive outcomes among children treated for Craniopharyngioma. J Pediatr Psychol. 2016;41(6):610\u201322. https:\/\/doi.org\/10.1093\/jpepsy\/jsw026.","journal-title":"J Pediatr Psychol"},{"key":"9972_CR134","doi-asserted-by":"publisher","first-page":"519607","DOI":"10.1155\/2010\/519607","volume":"2010","author":"HL Muller","year":"2010","unstructured":"Muller HL. Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol. 2010;2010:519607. https:\/\/doi.org\/10.1155\/2010\/519607.","journal-title":"Int J Endocrinol"},{"issue":"9197","key":"9972_CR135","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(99)05582-8.","journal-title":"Lancet"},{"key":"9972_CR136","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/ncomms3259","volume":"4","author":"SM Greer","year":"2013","unstructured":"Greer SM, Goldstein AN, Walker MP. The impact of sleep deprivation on food desire in the human brain. Nat Commun. 2013;4:2259. https:\/\/doi.org\/10.1038\/ncomms3259.","journal-title":"Nat Commun"},{"issue":"4","key":"9972_CR137","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/cen.13929","volume":"90","author":"CJ Thompson","year":"2019","unstructured":"Thompson CJ, Costello RW, Crowley RK. Management of hypothalamic disease in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2019;90(4):506\u201316. https:\/\/doi.org\/10.1111\/cen.13929.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"9972_CR138","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1365-2265.2011.03993.x","volume":"74","author":"RK Crowley","year":"2011","unstructured":"Crowley RK, Woods C, Fleming M, Rogers B, Behan LA, O\u2019Sullivan EP, et al. Somnolence in adult craniopharyngioma patients is a common, heterogeneous condition that is potentially treatable. Clin Endocrinol (Oxf). 2011;74(6):750\u20135. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.03993.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"9972_CR139","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jcem.87.8.8751","volume":"87","author":"HL Muller","year":"2002","unstructured":"Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab. 2002;87(8):3993\u20136. https:\/\/doi.org\/10.1210\/jcem.87.8.8751.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9972_CR140","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11892-014-0507-z","volume":"14","author":"CM Depner","year":"2014","unstructured":"Depner CM, Stothard ER, Wright KP Jr. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep. 2014;14(7):507. https:\/\/doi.org\/10.1007\/s11892-014-0507-z.","journal-title":"Curr Diab Rep"},{"issue":"21","key":"9972_CR141","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1161\/CIRCULATIONAHA.115.019392","volume":"133","author":"CH Lee","year":"2016","unstructured":"Lee CH, Sethi R, Li R, Ho HH, Hein T, Jim MH, et al. Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention. Circulation. 2016;133(21):2008\u201317. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019392.","journal-title":"Circulation"},{"key":"9972_CR142","doi-asserted-by":"publisher","unstructured":"Legault J, Thompson C, Martineau-Dussault ME, Andre C, Baril AA, Martinez Villar G, et al. Obstructive sleep apnea and cognitive decline: a review of potential vulnerability and protective factors. Brain Sci. 2021;11(6). https:\/\/doi.org\/10.3390\/brainsci11060706.","DOI":"10.3390\/brainsci11060706"},{"key":"9972_CR143","doi-asserted-by":"publisher","unstructured":"Gozal D, Almendros I, Phipps AI, Campos-Rodriguez F, Martinez-Garcia MA, Farre R. Sleep apnoea adverse effects on cancer: true, false, or too many confounders? Int J Mol Sci. 2020;21(22). https:\/\/doi.org\/10.3390\/ijms21228779.","DOI":"10.3390\/ijms21228779"},{"issue":"2","key":"9972_CR144","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5664\/jcsm.8986","volume":"17","author":"JD Edinger","year":"2021","unstructured":"Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255\u201362. https:\/\/doi.org\/10.5664\/jcsm.8986.","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"9972_CR145","first-page":"435","volume":"25","author":"CL Marcus","year":"2002","unstructured":"Marcus CL, Trescher WH, Halbower AC, Lutz J. Secondary narcolepsy in children with brain tumors. Sleep. 2002;25(4):435\u20139.","journal-title":"Sleep"},{"issue":"7","key":"9972_CR146","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/archpedi.1986.02140210108037","volume":"140","author":"MW Stelling","year":"1986","unstructured":"Stelling MW, McKay SE, Carr WA, Walsh JW, Baumann RJ. Frontal lobe lesions and cognitive function in craniopharyngioma survivors. Am J Dis Child. 1986;140(7):710\u20134. https:\/\/doi.org\/10.1001\/archpedi.1986.02140210108037.","journal-title":"Am J Dis Child"},{"issue":"2 Suppl","key":"9972_CR147","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3171\/ped.2006.104.2.5","volume":"104","author":"TE Merchant","year":"2006","unstructured":"Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg. 2006;104(2 Suppl):94\u2013102. https:\/\/doi.org\/10.3171\/ped.2006.104.2.5.","journal-title":"J Neurosurg"},{"issue":"5","key":"9972_CR148","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.ijrobp.2012.10.031","volume":"85","author":"KL Netson","year":"2013","unstructured":"Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE. Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys. 2013;85(5):1301\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.10.031.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"33","key":"9972_CR149","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1200\/JCO.2005.03.8547","volume":"24","author":"EN Kiehna","year":"2006","unstructured":"Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol. 2006;24(33):5283\u201390. https:\/\/doi.org\/10.1200\/JCO.2005.03.8547.","journal-title":"J Clin Oncol"},{"issue":"1","key":"9972_CR150","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/13803390802064599","volume":"31","author":"HN Bawden","year":"2009","unstructured":"Bawden HN, Salisbury S, Eskes G, Morehouse R. Neuropsychological functioning following craniopharyngioma removal. J Clin Exp Neuropsychol. 2009;31(1):140\u20134. https:\/\/doi.org\/10.1080\/13803390802064599.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"9972_CR151","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pediatrneurol.2005.06.002","volume":"34","author":"DP Waber","year":"2006","unstructured":"Waber DP, Pomeroy SL, Chiverton AM, Kieran MW, Scott RM, Goumnerova LC, et al. Everyday cognitive function after craniopharyngioma in childhood. Pediatr Neurol. 2006;34(1):13\u20139. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2005.06.002.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"9972_CR152","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00381-010-1301-0","volume":"27","author":"A Ondruch","year":"2011","unstructured":"Ondruch A, Maryniak A, Kropiwnicki T, Roszkowski M, Daszkiewicz P. Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma. Childs Nerv Syst. 2011;27(3):391\u20137. https:\/\/doi.org\/10.1007\/s00381-010-1301-0.","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"9972_CR153","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jpeds.2013.12.010","volume":"164","author":"J Ozyurt","year":"2014","unstructured":"Ozyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, et al. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr. 2014;164(4):876-81 e4. https:\/\/doi.org\/10.1016\/j.jpeds.2013.12.010.","journal-title":"J Pediatr"},{"issue":"8","key":"9972_CR154","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1210\/jc.2013-2000","volume":"98","author":"S Fjalldal","year":"2013","unstructured":"Fjalldal S, Holmer H, Rylander L, Elfving M, Ekman B, Osterberg K, et al. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab. 2013;98(8):3253\u201362. https:\/\/doi.org\/10.1210\/jc.2013-2000.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8\u20139","key":"9972_CR155","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00381-005-1205-6","volume":"21","author":"A Pierre-Kahn","year":"2005","unstructured":"Pierre-Kahn A, Recassens C, Pinto G, Thalassinos C, Chokron S, Soubervielle JC, et al. Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective series Childs Nerv Syst. 2005;21(8\u20139):817\u201324. https:\/\/doi.org\/10.1007\/s00381-005-1205-6.","journal-title":"A prospective series Childs Nerv Syst"},{"issue":"1","key":"9972_CR156","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1300\/j010v38n01_05","volume":"38","author":"AC Jackson","year":"2003","unstructured":"Jackson AC, Tsantefski M, Goodman H, Johnson B, Rosenfeld J. The psychosocial impacts on families of low-incidence, complex conditions in children: the case of craniopharyngioma. Soc Work Health Care. 2003;38(1):81\u2013107. https:\/\/doi.org\/10.1300\/j010v38n01_05.","journal-title":"Soc Work Health Care"},{"key":"9972_CR157","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cortex.2017.01.017","volume":"89","author":"J Ozyurt","year":"2017","unstructured":"Ozyurt J, Muller HL, Warmuth-Metz M, Thiel CM. Hypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areas. Cortex. 2017;89:98\u2013110. https:\/\/doi.org\/10.1016\/j.cortex.2017.01.017.","journal-title":"Cortex"},{"issue":"6","key":"9972_CR158","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1530\/EJE-18-0081","volume":"178","author":"S Fjalldal","year":"2018","unstructured":"Fjalldal S, Follin C, Svard D, Rylander L, Gabery S, Petersen A, et al. Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma. Eur J Endocrinol. 2018;178(6):577\u201387. https:\/\/doi.org\/10.1530\/EJE-18-0081.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"9972_CR159","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1016\/j.ijrobp.2012.03.066","volume":"84","author":"M Di Pinto","year":"2012","unstructured":"Di Pinto M, Conklin HM, Li C, Merchant TE. Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys. 2012;84(3):e363\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.066.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"9972_CR160","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11102-012-0428-2","volume":"16","author":"EM Erfurth","year":"2013","unstructured":"Erfurth EM, Holmer H, Fjalldal SB. Mortality and morbidity in adult craniopharyngioma. Pituitary. 2013;16(1):46\u201355. https:\/\/doi.org\/10.1007\/s11102-012-0428-2.","journal-title":"Pituitary"},{"issue":"4","key":"9972_CR161","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40618-014-0196-0","volume":"38","author":"E Profka","year":"2015","unstructured":"Profka E, Giavoli C, Bergamaschi S, Ferrante E, Malchiodi E, Sala E, et al. Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma. J Endocrinol Invest. 2015;38(4):413\u201320. https:\/\/doi.org\/10.1007\/s40618-014-0196-0.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"9972_CR162","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1210\/jc.2005-0185","volume":"90","author":"J Verhelst","year":"2005","unstructured":"Verhelst J, Kendall-Taylor P, Erfurth EM, Price DA, Geffner M, Koltowska-Haggstrom M, et al. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). J Clin Endocrinol Metab. 2005;90(8):4636\u201343. https:\/\/doi.org\/10.1210\/jc.2005-0185.","journal-title":"J Clin Endocrinol Metab"},{"key":"9972_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.783737","volume":"13","author":"E Scarano","year":"2022","unstructured":"Scarano E, Solari D, Riccio E, Arianna R, Somma T, Cavallo LM, et al. Craniopharyngioma and Metabolic Syndrome: A 5-Year Follow-Up Single-Center Experience. Front Neurol. 2022;13: 783737. https:\/\/doi.org\/10.3389\/fneur.2022.783737.","journal-title":"Front Neurol"},{"issue":"6","key":"9972_CR164","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00431-010-1347-8","volume":"170","author":"T Sahakitrungruang","year":"2011","unstructured":"Sahakitrungruang T, Klomchan T, Supornsilchai V, Wacharasindhu S. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. Eur J Pediatr. 2011;170(6):763\u20139. https:\/\/doi.org\/10.1007\/s00431-010-1347-8.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"9972_CR165","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2265.2009.03639.x","volume":"72","author":"J Simoneau-Roy","year":"2010","unstructured":"Simoneau-Roy J, O\u2019Gorman C, Pencharz P, Adeli K, Daneman D, Hamilton J. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. Clin Endocrinol (Oxf). 2010;72(3):364\u201370. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03639.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9972_CR166","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2147\/DMSO.S425399","volume":"16","author":"HZ Du","year":"2023","unstructured":"Du HZ, Chen K, Zhang LY, Zhang YL, Wu DN, Guo XY, et al. Blood Lipid disorders in post-operative craniopharyngioma children and adolescents and the improvement with recombinant human growth hormone replacement. Diabetes Metab Syndr Obes. 2023;16:3075\u201384. https:\/\/doi.org\/10.2147\/DMSO.S425399.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"9972_CR167","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1210\/jcem.87.4.8429","volume":"87","author":"AF Attanasio","year":"2002","unstructured":"Attanasio AF, Bates PC, Ho KK, Webb SM, Ross RJ, Strasburger CJ, et al. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status\u20133-year results from the HypoCCS Database. J Clin Endocrinol Metab. 2002;87(4):1600\u20136. https:\/\/doi.org\/10.1210\/jcem.87.4.8429.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9972_CR168","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1210\/jc.2004-0551","volume":"89","author":"AF Attanasio","year":"2004","unstructured":"Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, et al. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. J Clin Endocrinol Metab. 2004;89(10):4857\u201362. https:\/\/doi.org\/10.1210\/jc.2004-0551.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9972_CR169","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","volume":"86","author":"G Gotherstrom","year":"2001","unstructured":"Gotherstrom G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, Bengtsson B, et al. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab. 2001;86(10):4657\u201365. https:\/\/doi.org\/10.1210\/jcem.86.10.7887.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9972_CR170","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2265.2001.01320.x","volume":"55","author":"TA Abdu","year":"2001","unstructured":"Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin Endocrinol (Oxf). 2001;55(2):209\u201316. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01320.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"9972_CR171","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1210\/jc.2009-2013","volume":"95","author":"M Koltowska-Haggstrom","year":"2010","unstructured":"Koltowska-Haggstrom M, Geffner ME, Jonsson P, Monson JP, Abs R, Hana V, et al. Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency. J Clin Endocrinol Metab. 2010;95(6):2646\u201354. https:\/\/doi.org\/10.1210\/jc.2009-2013.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9972_CR172","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","volume":"27","author":"CM Weaver","year":"2016","unstructured":"Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, et al. The National Osteoporosis Foundation\u2019s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 2016;27(4):1281\u2013386. https:\/\/doi.org\/10.1007\/s00198-015-3440-3.","journal-title":"Osteoporos Int"},{"issue":"1","key":"9972_CR173","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1053\/beem.2001.0180","volume":"16","author":"G Saggese","year":"2002","unstructured":"Saggese G, Baroncelli GI, Bertelloni S. Puberty and bone development. Best Pract Res Clin Endocrinol Metab. 2002;16(1):53\u201364. https:\/\/doi.org\/10.1053\/beem.2001.0180.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9972_CR174","doi-asserted-by":"publisher","unstructured":"van Santen SS, Olsson DS, Hammarstrand C, Wijnen M, Fiocco M, van den Heuvel-Eibrink MM, et al. Body composition and bone mineral density in craniopharyngioma patients: a longitudinal study over 10 years. J Clin Endocrinol Metab. 2020;105(12). https:\/\/doi.org\/10.1210\/clinem\/dgaa607.","DOI":"10.1210\/clinem\/dgaa607"},{"issue":"3","key":"9972_CR175","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1055\/s-2003-39789","volume":"111","author":"HL Muller","year":"2003","unstructured":"Muller HL, Schneider P, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, et al. Volumetric bone mineral density in patients with childhood craniopharyngioma. Exp Clin Endocrinol Diabetes. 2003;111(3):168\u201373. https:\/\/doi.org\/10.1055\/s-2003-39789.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"9972_CR176","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1530\/EJE-13-0280","volume":"169","author":"KC Yuen","year":"2013","unstructured":"Yuen KC, Koltowska-Haggstrom M, Cook DM, Fox JL, Jonsson PJ, Geffner ME, et al. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction. Eur J Endocrinol. 2013;169(4):511\u20139. https:\/\/doi.org\/10.1530\/EJE-13-0280.","journal-title":"Eur J Endocrinol"},{"key":"9972_CR177","doi-asserted-by":"publisher","unstructured":"Rinonapoli G, Pace V, Ruggiero C, Ceccarini P, Bisaccia M, Meccariello L, et al. Obesity and Bone: A complex relationship. Int J Mol Sci. 2021;22(24). https:\/\/doi.org\/10.3390\/ijms222413662.","DOI":"10.3390\/ijms222413662"},{"issue":"5","key":"9972_CR178","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jbmr.5650080507","volume":"8","author":"DT Felson","year":"1993","unstructured":"Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 1993;8(5):567\u201373. https:\/\/doi.org\/10.1002\/jbmr.5650080507.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"9972_CR179","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00198-007-0487-9","volume":"19","author":"MW Hamrick","year":"2008","unstructured":"Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporos Int. 2008;19(7):905\u201312. https:\/\/doi.org\/10.1007\/s00198-007-0487-9.","journal-title":"Osteoporos Int"},{"issue":"6","key":"9972_CR180","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000223422","volume":"71","author":"AM Boot","year":"2009","unstructured":"Boot AM, van der Sluis IM, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency. Horm Res. 2009;71(6):364\u201371. https:\/\/doi.org\/10.1159\/000223422.","journal-title":"Horm Res"},{"issue":"9","key":"9972_CR181","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1056\/NEJM199202273260904","volume":"326","author":"JS Finkelstein","year":"1992","unstructured":"Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992;326(9):600\u20134. https:\/\/doi.org\/10.1056\/NEJM199202273260904.","journal-title":"N Engl J Med"},{"issue":"4","key":"9972_CR182","first-page":"257","volume":"55","author":"CL Gordon","year":"1991","unstructured":"Gordon CL, Halton JM, Atkinson SA, Webber CE. The contributions of growth and puberty to peak bone mass. Growth Dev Aging. 1991;55(4):257\u201362.","journal-title":"Growth Dev Aging"},{"issue":"6","key":"9972_CR183","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/EJE-14-0865","volume":"173","author":"V Saraff","year":"2015","unstructured":"Saraff V, Hogler W. ENDOCRINOLOGY AND ADOLESCENCE: Osteoporosis in children: diagnosis and management. Eur J Endocrinol. 2015;173(6):R185\u201397. https:\/\/doi.org\/10.1530\/EJE-14-0865.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"9972_CR184","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1210\/jcem.81.3.8772591","volume":"81","author":"JS Finkelstein","year":"1996","unstructured":"Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab. 1996;81(3):1152\u20135. https:\/\/doi.org\/10.1210\/jcem.81.3.8772591.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9972_CR185","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ecl.2017.07.005","volume":"46","author":"IR Reid","year":"2017","unstructured":"Reid IR, Vitamin D. Effect on bone mineral density and fractures. Endocrinol Metab Clin North Am. 2017;46(4):935\u201345. https:\/\/doi.org\/10.1016\/j.ecl.2017.07.005.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"9972_CR186","doi-asserted-by":"publisher","unstructured":"Golden NH, Abrams SA, Committee on N. Optimizing bone health in children and adolescents. Pediatrics. 2014;134(4):e1229\u201343. https:\/\/doi.org\/10.1542\/peds.2014-2173.","DOI":"10.1542\/peds.2014-2173"},{"issue":"1","key":"9972_CR187","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1210\/clinem\/dgad488","volume":"109","author":"N Kayadjanian","year":"2023","unstructured":"Kayadjanian N, Hsu EA, Wood AM, Carson DS. Caregiver burden and its relationship to health-related quality of life in craniopharyngioma survivors. J Clin Endocrinol Metab. 2023;109(1):e76\u201387. https:\/\/doi.org\/10.1210\/clinem\/dgad488.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9972_CR188","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/pon.3649","volume":"24","author":"LP Barakat","year":"2015","unstructured":"Barakat LP, Li Y, Hobbie WL, Ogle SK, Hardie T, Volpe EM, et al. Health-related quality of life of adolescent and young adult survivors of childhood brain tumors. Psychooncology. 2015;24(7):804\u201311. https:\/\/doi.org\/10.1002\/pon.3649.","journal-title":"Psychooncology"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09972-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-025-09972-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09972-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:03:23Z","timestamp":1762877003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-025-09972-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":188,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9972"],"URL":"https:\/\/doi.org\/10.1007\/s11154-025-09972-7","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"21 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}